As filed with the Securities and Exchange Commission on February 24, 2004
Delaware | 52-1984749 | |
(State or Other Jurisdiction of Incorporation or | (I.R.S. Employer | |
Organization) | Identification Number) |
1110 Spring Street
Silver Spring, MD 20910
(301) 608-9292
(Address, Including Zip Code, and Telephone Number, Including Area Code, of
Registrants Principal Executive Offices)
Approximate date of commencement of proposed sale of the securities to the public: Not applicable.
If any of the securities being registered on this form are being offered pursuant to dividend or interest reinvestment plans, please check the following box. ____
If any of the securities being registered on this form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following box. ____
If this form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ____
If this form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ____
If delivery of the prospectus is expected to be made pursuant to Rule 434, please check the following box. ____
EXPLANATORY STATEMENT
Pursuant to this Post-Effective Amendment to its Registration Statement on Form S-3 (Registration No. 333-62616), United Therapeutics Corporation deregisters all shares of its common stock, par value $0.01 per share, heretofore registered and not previously sold.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Silver Spring, County of Montgomery, State of Maryland on the 23rd day of February, 2004.
UNITED THERAPEUTICS CORPORATION | ||
By: |
/s/ Martine A. Rothblatt |
|
Martine A. Rothblatt |
||
Chairman and Chief
Executive Officer |
Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed below by the following persons in the capacities and on the dates stated.
Signatures | Title | Date | ||
/s/ Martine A. Rothblatt |
Chairman and Chief Executive Officer | February 23, 2004 | ||
Martine A. Rothblatt |
||||
/s/ Fred T. Hadeed |
Chief Financial Officer | February 19, 2004 | ||
Fred T. Hadeed |
||||
/s/ Roger Jeffs Roger Jeffs |
President, Chief Operating Officer and Director | February 23, 2004 | ||
/s/ Ricardo Balda |
Director | February 23, 2004 | ||
Ricardo Balda |
||||
/s/ Christopher Causey |
Director | February 20, 2004 | ||
Christopher Causey |
/s/ Raymond A. Dwek |
Director | February 19, 2004 | ||
Raymond A. Dwek |
||||
/s/ R. Paul Gray |
Director | February 23, 2004 | ||
R. Paul Gray |
||||
/s/ H. Beecher Hicks, III |
Director | February 20, 2004 | ||
H. Beecher Hicks, III |
||||
/s/ Raymond Kurzweil |
Director | February 19, 2004 | ||
Raymond Kurzweil |
||||
/s/ Christopher Patusky |
Director | February 23, 2004 | ||
Christopher Patusky |
||||
Director | ||||
Louis W. Sullivan |